Thursday, 28 October 2021


Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine

Heartening upsurge IN CARDIAC MEDTECH R&D


Cardiovascular disease (CVD) remains the world’s number one killer, resulting in 18.6 million deaths a year. The global focus on the pandemic, neglecting the real numbers of patients dying due to heart disease, among other life-threatening disorders, is illogical and staggering, to say the least. ‘Harnessing the power of technology to improve awareness, prevention and management of CVDs’, globally, is the goal for World Heart Day 2021, observed on September 29 every year. Moreover, the increasing cases of CVDs within the APAC region have, in turn, pushed the growth of the cardiovascular devices market as it currently offers a range of stents, catheters, cardiac rhythm management devices, pacemakers etc. An increasing number of startups and medical innovations in the APAC countries are projected to take the medtech ecosystem to the next level in cardiac care.
 

For Feedback Email Us : communications@biospectrumasia.com

Click here to access E-magazine



BioSpectrum Infomercial

Coming soon: a new era of mAb manufacturing